Westfield Capital Management’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $36.1M | Sell |
1,152,605
-238,765
| -17% | -$7.47M | 0.15% | 168 |
|
|
2025
Q1 | $46.7M | Buy |
1,391,370
+234,181
| +20% | +$7.86M | 0.23% | 138 |
|
|
2024
Q4 | $45.4M | Buy |
1,157,189
+487,589
| +73% | +$19.1M | 0.2% | 144 |
|
|
2024
Q3 | $26.4M | Buy |
669,600
+26,054
| +4% | +$1.03M | 0.12% | 174 |
|
|
2024
Q2 | $25.1M | Buy |
643,546
+296,195
| +85% | +$11.5M | 0.12% | 180 |
|
|
2024
Q1 | $15M | Buy |
347,351
+109,856
| +46% | +$4.73M | 0.08% | 188 |
|
|
2023
Q4 | $10.9M | Buy |
+237,495
| New | +$10.9M | 0.06% | 187 |
|